Search - tctmd.com

Displaying 61 - 80 of 103

Sort: Relevancy | Date

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

News Daily News

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

December 18, 2018

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

More Research Supports Use of Aspirin Alone to Prevent VTE After Knee Replacement Surgery

News Daily News

More Research Supports Use of Aspirin Alone to Prevent VTE After Knee Replacement Surgery

October 18, 2018

News Industry News

Veryan Medical receives PMA approval for BioMimics 3D

October 05, 2018

IMPERIAL: Eluvia Tops Zilver PTX in Battle of DES in Femoropopliteal Disease

News Conference News TCT 2018

IMPERIAL: Eluvia Tops Zilver PTX in Battle of DES in Femoropopliteal Disease

September 22, 2018

FDA Advisory Panel Gives Thumbs Up to EVAR System

News Daily News

FDA Advisory Panel Gives Thumbs Up to EVAR System

June 14, 2018

Real-World Study Raises Concerns About Initiating Carotid Stenting in Acute Phase

News Daily News

Real-World Study Raises Concerns About Initiating Carotid Stenting in Acute Phase

April 03, 2018

News Industry News

Endospan Receives CE Mark for HORIZON™ EVAR System Based on Robust Clinical and Pivotal Data to Treat Abdominal Aortic Aneurysm (AAA)

March 22, 2018

Aspirin Switch for VTE Prevention After Hip/Knee Arthroplasty: Safe, Effective, and Cost-Saving in EPCAT II

News Daily News

Aspirin Switch for VTE Prevention After Hip/Knee Arthroplasty: Safe, Effective, and Cost-Saving in EPCAT II

Michael O'Riordan

February 21, 2018

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

News Daily News

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

February 11, 2018

More Stroke Thrombectomy Studies Offer Insights Into Subgroups, New Devices, and Lytic Choice

News Conference News ISC 2018

More Stroke Thrombectomy Studies Offer Insights Into Subgroups, New Devices, and Lytic Choice

January 31, 2018

Penumbra Separator 3D: Another Brick in the Wall Supporting Aspiration for Acute Stroke

News Daily News

Penumbra Separator 3D: Another Brick in the Wall Supporting Aspiration for Acute Stroke

January 08, 2018

EVAR Shown to IMPROVE Outcomes Over Surgery for Ruptured AAA Patients

News Daily News

EVAR Shown to IMPROVE Outcomes Over Surgery for Ruptured AAA Patients

November 17, 2017

TCTMD’s Top 10 Most Popular Stories for October 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2017

October 29, 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

October 20, 2017

Lower Limb Revascularizations Increasing in PAD Patients on Dialysis

News Daily News

Lower Limb Revascularizations Increasing in PAD Patients on Dialysis

October 18, 2017

TCTMD’s Top 10 Most Popular Stories for September 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2017

September 30, 2017

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

News Conference News VIVA 2017

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

September 18, 2017

ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA

News Conference News VIVA 2017

ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA

September 15, 2017

My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back

News Opinion Editor's Corner ESC 2017

My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back

September 08, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.